As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...

The Indianapolis Public Library unveiled its new Libraries with Heart initiative. Visitors can check their blood pressure for ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

In fact, although never before so brutally and blatantly, the United States has bribed and bullied the WHO from the earliest ...

The global antidiabetics market is on a strong growth trajectory, with sales projected to soar from USD 106.3 billion in 2024 to USD 298.2 billion by 2034. This substantial increase reflects a robust ...

According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.

Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer ...

A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...

Other tech giants are following suit. Microsoft has reiterated plans to invest more than $40 billion in U.S. data centers, while Amazon Web Services has committed $11 billion to expand its ...

Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.